Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
European Journal of Endocrinology|June 23, 2012
Thyroid hormone transporters and deiodinases in the developing human hypothalamusEdith C H Friesema, Theo J Visser, Anke J Borgers, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2012
AgRP and NPY expression in the human hypothalamic infundibular nucleus correlate with body mass index, whereas changes in αMSH are related to type 2 diabetesAnneke Alkemade, Chun-Xia Yi, Lei Pei, et al.
Diabetes|March 31, 2012
Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous systemEveline Bruinstroop, Lei Pei, Mariëtte T Ackermans, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 6, 2013
Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effectsElodie M Girault, Bruno Guigas, Anneke Alkemade, et al.
EJNMMI Research|April 27, 2013
Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamusAnke J Borgers, Anneke Alkemade, Elsmarieke M Van de Giessen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2004
Thyroid hormone receptor expression in the human hypothalamus and anterior pituitaryAnneke Alkemade, Chrétienne L Vuijst, Unga A Unmehopa, et al.
Neuroimage|May 5, 2015
The Age-ility Project (Phase 1): Structural and functional imaging and electrophysiological data repositoryFrini Karayanidis, Max C Keuken, Aaron Wong, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2013
Arginine vasopressin immunoreactivity is decreased in the hypothalamic suprachiasmatic nucleus of subjects with suprasellar tumorsAnke J Borgers, Eric Fliers, Jacqueline E Siljee, et al.
Frontiers in Neuroscience|May 27, 2014
Decreased serotonin transporter immunoreactivity in the human hypothalamic infundibular nucleus of overweight subjectsAnke J Borgers, Karin E Koopman, Peter H Bisschop, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes PatientsJennifer S Ten Kulve, Liselotte van Bloemendaal, Rawien Balesar, et al.
Pageof 16